Home » Topics » Regulatory » Patents

Patents
RSS

New antiinflammatory agents from Procter & Gamble

July 8, 1997

MS&D discloses selective 5-HT1D agonists

July 8, 1997

Agents for BPH claimed by Merck & Co.

July 8, 1997

SmithKline Beecham reports novel hemoregulatory compounds

July 8, 1997

Novartis discovers compounds with anti-PDE IV and other actions

July 8, 1997

AHP discloses agents useful for disorders of the dopaminergic system

July 8, 1997

Inhibitors of tyrosine kinase disclosed by Pharmacia & Upjohn

July 7, 1997

MMP/TNF-alpha inhibitors from Abbott

July 7, 1997

HIV protease inhibitors described by Searle

July 7, 1997

Synaptic and Merck & Co. prepare selective human alpha1A-adrenoceptor antagonists

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...